# Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination

> **NCT04629352** · NA · RECRUITING · sponsor: **National Institute of Mental Health and Neuro Sciences, India** · enrollment: 72 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DEVICE:** Verum Accelerated Transcranial Direct Current Stimulation (acctDCS)
- **DEVICE:** Sham Accelerated Transcranial Direct Current Stimulation (acctDCS)

## Key facts

- **NCT ID:** NCT04629352
- **Lead sponsor:** National Institute of Mental Health and Neuro Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04629352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04629352, "Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04629352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*